The Federal Agency for Medicines and Health Products (FAMHP) is the Belgian competent authority in charge of ensuring the quality, safety and efficacy of medicines and health products (medical devices and accessories, raw materials, blood and blood products of human origin, human tissue material), for human and veterinary use, in clinical development and on the market.

The famhp works together with the academic world, the pharmaceutical industry and the other industries concerned, healthcare professionals, other national, European and worldwide authorities, as well as policy makers, in order to provide everybody with the necessary medicines and health products and to help patients and citizens to use them correctly.

The famhp has grown since its creation from an organization with a few dozen employees to an agency that has more than 500 employees which are mostly scientifically trained. The agency consists out of five entities: three Directorates-General, DG PRE authorisation, DG  POST authorisation and DG INSPECTION, the support services and the CEO Services.

Health Data

Life Sciences

Medical Devices

Pharmaceutical

FAMHP - Federal Agency for Medicines and Health Products

Hugues Malonne

Guy Janssens

Brouyere Michel

The Scientific and Quality Assessment team at FAMHP is responsible for evaluating the quality, safety, and efficacy of medicines and health products. This multidisciplinary team conducts thorough scientific reviews of clinical data, biological assessments, and pharmacovigilance reports to ensure compliance with regulatory standards. Their work involves close collaboration with healthcare professionals, industry stakeholders, and international authorities to safeguard public health and support informed decision-making.

Scientific and Quality Assessment

Administration and Support

Software Development Team

Scientific and Quality Assessment

About

Team members

Other teams at FAMHP - Federal Agency for Medicines and Health Products

Administration and Support

Software Development Team